Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability.
JS, S., D, G.A., M, M., T, M., L, H., & AR, J. (2026). Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability.. Molecular genetics & genomic medicine. https://doi.org/10.1002/mgg3.70261
JS S, D GA, M M, T M, L H, AR J. Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability.. Molecular genetics & genomic medicine. 2026; doi: 10.1002/mgg3.70261
JS S, D GA, M M, et al. Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability.[J]. Molecular genetics & genomic medicine. 2026. DOI: 10.1002/mgg3.70261.
@article{js2026,
author = {Singer JS and Garczarczyk-Asim D and Michel M and Müller T and Hackl L and Janecke AR},
title = {Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability.},
journal = {Molecular genetics & genomic medicine},
year = {2026},
doi = {10.1002/mgg3.70261},
note = {PMID: 42444102},
}
TY - JOUR AU - Singer JS AU - Garczarczyk-Asim D AU - Michel M AU - Müller T AU - Hackl L AU - Janecke AR TI - Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability. T2 - Molecular genetics & genomic medicine PY - 2026 DO - 10.1002/mgg3.70261 AN - PMID:42444102 ER -
INTRODUCTION: Loss-of-function variants in NONO cause an X-linked syndromic neurodevelopmental disorder (MRXS34), characterized by developmental delay, corpus callosum abnormalities, dysmorphic features, feeding difficulties, and congenital heart disease, most commonly left ventricular noncompaction cardiomyopathy (LVNC). Long-term outcome data remain limited. METHODS: A 14-year-old boy with LVNC and syndromic neurodevelopmental features underwent exome sequencing and subsequently NONO transcript analysis. A literature search was conducted using the terms "NONO variant" and "NONO mutation". RESULTS: Exome sequencing identified a hemizygous NONO variant, c.348G>A, absent from population databases. This silent mutation was predicted in silico to cause exon 4 skipping, resulting in a frameshift and a premature termination codon p.(Asn52Argfs*31). This prediction was confirmed by RT-PCR, and it was demonstrated that the aberrant transcript was subject to nonsense-mediated mRNA decay. The patient displayed the characteristic NONO-associated phenotype with rapid cardiac deterioration requiring pulsatile left ventricular assist device implantation at 1 year of age, and orthotopic heart transplantation at 2 years of age. At 14 years, graft function remains stable. An emergency hemicolectomy due to volvulus was performed at 12 years of age. A literature search identified 32 live-born patients and 11 fetuses with NONO loss-of-function mutations. Intellectual disability, particularly affecting language development, LVNC, a recognizable facial phenotype, dystrophy, and lean habitus were nearly invariantly present. CONCLUSION: This report further emphasizes the core phenotype caused by NONO loss-of-function, describes the second individual with heart transplantation, and indicates an underrecognized prevalence of gastrointestinal features.